Division of Pharmaceutical, Administrative and Social Sciences, Duquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, 15282, USA.
Division of Health Outcomes and Pharmacy Practice, The University of Texas at Austin College of Pharmacy, 2409 University Ave Stop A1900, Austin, TX, 78712, USA.
Support Care Cancer. 2019 May;27(5):1613-1637. doi: 10.1007/s00520-019-04675-7. Epub 2019 Feb 8.
Shared decision-making (SDM) is a strategy to facilitate patient-centered care and is increasingly important in oncology, where patients are faced with complicated treatment decisions that require them to weigh efficacy and safety, quality of life, and cost. Understanding the contributors to the use of SDM may provide insight to its further implementation. Therefore, the objective of the study was to examine the patient-related barriers/facilitators to SDM in oncology care.
A systematic literature review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was executed. A search strategy composed of cancer, decision-making, and patient-centered terms was conducted utilizing PubMed, EBSCO MEDLINE, Scopus, CINAHL, and the Cochrane Library databases between January 2007 and November 2017. Full-text, US-based, English language articles describing the patient perspective of SDM in oncology care were included. Relevant data from articles were reviewed in a qualitative synthesis.
From 3435 potential citations, a total of 35 articles were included. The most common cancers studied were breast (n = 22; 62.9%) and prostate (n = 9; 25.7%). The identified themes for barriers to SDM were uncertainty in the treatment decision, concern regarding adverse effects, and poor physician communication. Themes for facilitators for SDM included physician consideration of patient preferences, positive physician actions and behaviors, and use or encouragement of support systems.
As SDM gains use within oncology practice, understanding key influences will allow for more effective implementation of strategies to increase patient engagement and improve care and value in the treatment process.
共同决策(SDM)是一种促进以患者为中心的护理的策略,在肿瘤学中越来越重要,因为患者面临着需要权衡疗效和安全性、生活质量和成本的复杂治疗决策。了解使用 SDM 的影响因素可能为其进一步实施提供见解。因此,本研究的目的是探讨肿瘤护理中 SDM 的患者相关障碍/促进因素。
使用系统评价和荟萃分析的首选报告项目(PRISMA)进行了系统的文献回顾。使用癌症、决策和以患者为中心的术语的搜索策略,利用 PubMed、EBSCO MEDLINE、Scopus、CINAHL 和 Cochrane 图书馆数据库,在 2007 年 1 月至 2017 年 11 月之间进行了搜索。纳入了描述肿瘤护理中 SDM 的患者观点的全文、基于美国的、英语语言的文章。对文章中的相关数据进行了定性综合分析。
从 3435 个潜在引文中共纳入了 35 篇文章。研究中最常见的癌症是乳腺癌(n=22;62.9%)和前列腺癌(n=9;25.7%)。阻碍 SDM 的主题包括治疗决策的不确定性、对不良反应的担忧以及医生沟通不佳。促进 SDM 的主题包括医生考虑患者的偏好、医生的积极行动和行为以及使用或鼓励支持系统。
随着 SDM 在肿瘤学实践中的应用增加,了解关键影响因素将有助于更有效地实施增加患者参与度、改善护理和提高治疗过程价值的策略。